Catecholaminergic Polymorphic Ventricular Tachycardia Panel
New York
Approved
Genes
Conditions
- Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Clinical Utility
- Confirmation of a clinical diagnosis in symptomatic patients
- Risk assessment of asymptomatic family members of a proband with CPVT
- Recurrence risk calculation
- Differentiation of hereditary CPVT from other acquired or genetic heart conditions
- Prenatal diagnosis in families with a known mutation
Lab Method
- Deletion/Duplication Analysis
- Next-Gen Sequencing
Test Code
482
CPT Codes*
81403x1, 81405x1, 81408x1
ABN Required
No
Turnaround Time**
4 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Reporting times are typical and begin once the sample(s) are received at the GeneDx laboratory, but could be extended in situations outside GeneDx’s reasonable control.
Test Documents
Billing
For Providers
Targeted Variant Testing